An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.
Experimental Drug Gaining Popularity Via Social Media
The experimental drug, which is still in research studies, is being promoted by online personalities for its supposed weight-reducing effects. Viewers are urged to contact these profiles privately for supplier links, while also receiving promotional offers.
Active Trade on Messaging Platforms
Separately, a flourishing market exists on messaging services, where groups with numerous of members share comparison images, administration instructions and claims of rapid UK delivery. Sellers market the substance there before directing customers to other platforms for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Early trials indicate it could help individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.
Medical Experts Express Worries
Nevertheless, physicians and chemists have cautions that the distribution of what remains an unapproved drug in the UK is a cause for concern and could result in individuals administering substances of uncertain source.
Some experts stated the demand for the experimental drug could be linked to the increasing price of licensed weight loss products such as Mounjaro.
Legal Position and Implementation
Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach medicines, advertising, and consumer regulations, potentially leading to fines, prosecution or imprisonment.
Platform Response and Content Removal
Based on TikTok, the platform has taken down problematic content and banned related keywords and search suggestions. The company stated it was committed to keeping the service secure and investing in strengthening compliance measures.
Digital Marketplace Activities
Investigations also discovered communities with up to nine thousand participants selling the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays channels with numerous of members, populated with images of weight loss, glowing testimonials and detailed instructions for preparing or injecting at residence.
Within moments of entering one group, a vendor shared contact information, where most transactions take place. The seller provided an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about body mass, health issues or previous experience.
Item Information and Pricing
Within these communities, messages show black plastic packages with postal service labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20mg. When questioned how much time a pen should last, sellers give conflicting answers ranging from a several days to “depends on your body”.
Platform Oversight and Safety Measures
A representative for Telegram stated it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting substances they cannot confirm. Even if the research behind this drug is sound, these online versions may not include what they claim,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service connected the increase in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.
Her team has already seen patients injured by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” said the doctor. “These substances could be impure or improperly measured.”
Manufacturer Position
A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may subject patients to possibly serious health risks”.
